News Releases
2010
- Mochida announces Termination of License Agreement with Wyeth
(April 13, 2010) (HTML)
- Overview of the Mochida Pharmaceutical Group’s “10-12 Medium Term Management Plan”
(April 1, 2010) (HTML)
- Conclusion of Co-marketing Agreement for an Anti-Depressant, Escitalopram in Japan
(January 7, 2010) (HTML)
2009
- Conclusion of Distributorship Agreement Concerning Switch-OTC Drug for Hyperlipidemia Treatment, Epadel
(April 30, 2009) (HTML)
- Overview of the Mochida Pharmaceutical Group’s “09-11 Medium Term Management Plan”
(April 1, 2009) (HTML)
- Mochida Concludes License Agreement for LIALDA® - A Once-Daily Treatment for Ulcerative Colitis
(January 16, 2009) (HTML)
2008
- Overview of the Mochida Pharmaceutical Group’s “08-10 Medium Term Management Plan”
(April 1, 2008) (HTML) - Transfer of Marketing Authorizations and Distribution Rights for Bone Metabolism Marker “OSTEOMARK” and “OSTEOMARK NTx SERUM”
(March 3, 2008) (HTML) - Mochida Announces Conclusion of License Agreement with Wyeth
(January 9, 2008) (HTML) - Mochida Launches Dinagest Tab. 1mg - A Treatment for Endometriosis
(January 7, 2008) (HTML)
2007
- Co-development and Commercialization Agreement For a Cellular-based Drug Using Human Mesenchymal Stem Cells For the Treatment of Graft-versus-Host Disease
(December 21, 2007) (HTML) - Mochida Launches Beselna Cream 5% - First Therapeutic Agent for Condyloma Acuminatum in Japan
(November 26, 2007) (HTML) - Mochida Obtains Approval for Dinagest Tab. 1mg - A Treatment for Endometriosis
(October 22, 2007) (HTML) - Overview of the Mochida Pharmaceutical Group’s “07-09 Medium Term Management Plan”
(April 2, 2007) (HTML) - Novartis and Mochida to co-promote Diovan in Japan
(January 22, 2007) (HTML)
2006
- Epadel Inhibits Coronary Heart Disease and Reduces Recurrence
New Findings from the JELIS Large Scale Clinical Study
(November 15, 2006) (HTML) - Epadel Reduces Risk of Stroke Recurrence
New Results of JELIS Major Clinical Trial
(November 13, 2006) (HTML) - Medilaser Soft Pulse 10
New diode laser therapeutic device
relieves muscle/joint pain with pulsed laser radiation
(November 9, 2006) (HTML) - Mochida Pharmaceutical Wins at 12th Annual Nikkei BP Advertising Awards
(May 16, 2006) (HTML) - Overview of the Mochida Pharmaceutical Group’s “06-08 Medium Term Management Plan”
(April 3, 2006) (HTML) - New SONOVISTA G60 S high-performance 4D full-digital color
Doppler ultrasound diagnostic system set for release
(January 30, 2006) (HTML) - Greetings from the President
(January 30, 2006) (HTML) - Collage Furfur Liquid Soap To Be Japan’s First Medical Liquid Soap with Double Antibacterial and Antifungal Effects
Free Yourself From Harmful Fungi
(January 27, 2006) (HTML)
2005
- Completion of the Early Phase II Clinical Study of “Epadel” for Alzheimer's Disease
(December 12, 2005) (HTML) - The Results of a major clinical trial (“JELIS”) to investigate the efficacy of "Epadel” were presented in a meeting of the American Heart Association (AHA)
(November 15, 2005) (HTML) - SONOVISTA G40 High-Performance Full-Digital Color Doppler
Ultrasound Diagnostic System Joins the SONOVISTA Lineup
(June 30, 2005) (HTML) - Mochida Pharmaceutical To Independently Distribute
Low-dose Oral Contraceptives ORTHO®777-21 and ORTHO®M-21
(May 30, 2005) (HTML) - Mochida Pharmaceutical Group
Numerical Management Targets for Fiscal Year 2007
(April 18, 2005) (HTML) - Mochida Pharmaceutical Plant to Commence Operations
Independent of the Drug Manufacturing Division of Mochida Pharmaceutical
(March 31, 2005) (HTML) - Mochida Announces Completion of "JELIS" Major Clinical Trial for "Epadel"
Hyperlipidemia and Arteriosclerosis Obliterans Therapeutic Treatment
(March 22, 2005) (HTML) - Mochida to Launch EPA Products Epadel S600 and Epadel S300 in New Stick-Type Package Starting February 1st
(January 31, 2005) (HTML)
2004
- Improved Flavor for FLORID ORAL GEL (Therapeutic Agent for Oral and Esophageal Candidiasis) for Easy Administration
(September 15, 2004) (HTML) - Innovative Package Design Graces Launch of Collage Furfur – The Only Medical-Grade Scalp-Care Shampoo in Japan That Prevents Dandruff-Causing Fungi
New “ForeFinger” font to be employed for the first time in Japan
(August 24, 2004) (HTML) - Business and Capital Alliance with the Siemens Group
(July 16, 2004) (HTML) - EPA Product Epadel S900 Set to Offer New Dose and Innovative Stick-Type Packaging Beginning July 12th
(July 8, 2004) (HTML) - New SONOVISTA C3000 Ultrasound Diagnostic System Added to SONOVISTA Series, Featuring Five-Frequency Probe for High Precision Imaging
(June 16, 2004) (HTML) - Overview of the Mochida Pharmaceutical Group’s
"04-06 Medium-Term Management Plan" for the Fiscal Years 2004-2006
(April 28, 2004) (HTML) - Mochida Healthcare Co., Ltd Set To Commence Independent Operations
As Subsidiary of Healthcare Product Division of Mochida Pharmaceutical Co., Ltd.
(April 1, 2004) (HTML) - Approval for Epadel S900, EPA Product with New Dose
A Therapeutic Agent for the Treatment of Hyperlipidemia and Arteriosclerosis Obliterans
(March 15, 2004) (HTML)
2003
- New Sales Hub for Blood Coagulation Inhibitor "Novo-Heparin Injection 1000" and Heparin Antagonist "Novo-Protamin Sulfate"
(August 28, 2003) (HTML) - New Collage S Series Cosmetics Line Set for Release
Evolved from Standard Collage Series For Sensitive and Dry Skin
(August 20, 2003) (HTML) - Mochida's Liquid Thrombin Softbottle Wins Japan's Highest Packaging Honor
(August 1, 2003) (HTML) - Joint Commercialization of a Qualitative Urinary Trypsinogen-2 Diagnostic Test
(July 7, 2003) (HTML) - Mochida Pharmaceutical Repackages Thrombin MOCHIDA To Prevent Inappropriate Usage
(June 23, 2003) (HTML) - Mochida Launches "ABaer™ Cub™" - A Portable Automated ABR Test Device
(May 6, 2003) (HTML) - Mochida Launches the FM-2 - A Compact, Lightweight Antepartum Fetal Monitor for Emergency and Transit Use
(April 23, 2003) (HTML)
2002
- Mochida Pharmaceutical and JCR Pharmaceuticals reluctantly abandon attempts to obtain approval for Thrombomodulin
(November 6, 2002) (HTML) - Latest News on Thrombomodulin
(September 27, 2002) (HTML) - Development of SSRI (Selective Serotonin Re-uptake Inhibitor)
(May 31, 2002) (HTML) - Sales Tie-up on Suprecur® and Suprecur® MP1.8, GnRH Analogue
(May 20, 2002) (HTML) - Vitacollage Health and Beauty Supplements
(April 18, 2002) (HTML) - Letter of Intent for distribution of SONOLINE® Antares
(April 17, 2002) (HTML) - ISO 14001 Environmental Certification for Otawara Plant
(April 2, 2002) (HTML)